Definition:Market value margin (MVM)
📊 Market value margin (MVM) is a component of technical provisions under certain solvency frameworks that represents the additional cost a third party would demand, above the best estimate liability, to assume an insurer's insurance obligations. The concept reflects the idea that a willing buyer of a portfolio of insurance liabilities would require compensation for the uncertainty and non-hedgeable risks embedded in those obligations — risks that cannot be fully eliminated through reinsurance or financial instruments. Under Solvency II in the European Union, this margin is formally termed the risk margin and is calculated using a cost-of-capital approach, while the Swiss Solvency Test (SST) employs a conceptually similar market value margin. The terminology and precise methodology differ across jurisdictions, but the underlying principle — that technical provisions should approximate a transfer value rather than just an actuarial best estimate — is shared across modern risk-based regimes.
⚙️ The standard calculation projects the future solvency capital requirement for non-hedgeable risks over the full run-off period of the liabilities, then applies a prescribed cost-of-capital rate to each year's projected capital charge and discounts the resulting stream back to the valuation date. Under Solvency II, the cost-of-capital rate is set at six percent, a parameter that has attracted sustained debate about whether it overstates the true market price of bearing insurance risk. Because projecting future SCR figures year by year is computationally intensive — particularly for long-duration life insurance and annuity portfolios — regulators permit simplified methods, including proportional approximations that scale the margin from a single valuation-date SCR. The resulting MVM is added to the best estimate liability to form the total technical provisions on the balance sheet, directly influencing an insurer's own funds and solvency ratio.
💡 For long-tail lines such as pension annuities or disability covers, the MVM can be material — sometimes rivaling or exceeding the present value of future profits on a book of business. This has tangible strategic consequences: it can discourage insurers from writing very long-duration products, since the solvency cost of holding the margin erodes returns on capital. The 2019 Solvency II review and the UK's subsequent post-Brexit reforms under the Solvency UK initiative specifically targeted the risk margin calibration, with the UK ultimately adopting a modified methodology that tapers the margin for long-dated liabilities. Across markets, the treatment of this margin remains one of the most consequential technical choices in insurance regulation, shaping product pricing, capital management, and the competitive dynamics between jurisdictions.
Related concepts: